Trial Profile
A retroseptcive study investigating efficacy of switching from 0.005% latanoprost to 0.01% bimatoprost in primary open-angle glaucoma patients who underwent intraocular pressure elevation during treatment
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 17 Oct 2016
Price :
$35
*
At a glance
- Drugs Bimatoprost (Primary)
- Indications Open-angle glaucoma
- Focus Therapeutic Use
- 17 Oct 2016 New trial record